Skip to content
value.today

Hims & Hers Health, Inc.

HIMS
$7.0 Bmarket cap on Oct 30, 2026+262.4% since Jan 2024
Compare
World rank
#2,840
Revenue
$2.3 B
For year ending December-2025
Net income
$128 M
5.5% margin
SEC filing
Employees
398
As on 2021
value.today research

Hims & Hers Health, Inc. in brief

Hims & Hers Health, Inc. is a listed company in the FMCG industry, based in San Francisco, California, USA. It was founded in 2017. Its market value was $7.0 B on 30 October 2026, which makes it the 2,840th largest listed company in the world and the 869th largest in the USA on this site. In the year to December 2025 it had sales of $2.3 B and a net profit of $128 M, about 5 cents of profit for every dollar of sales. It employs about 398 people and Andrew Dudum is its chief executive. By market, the largest shares of its 2025 sales came from USA (94%). Its shares trade under the symbol HIMS (NYSE).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Hims & Hers Health, Inc.

Hims & Hers Health, Inc., doing business as hims, is an American telehealth company headquartered in San Francisco. It provides prescription medications, over-the-counter medications, and personal care products through a direct-to-consumer subscription model.

From Wikipedia: read the full article · text available under CC BY-SA 4.0

Hims & Hers Health, Inc. timeline

7 events, 2017–2025
  1. 2017
  2. 🏁
    · approximate
    Founded
  3. 2019
  4. 🔔
    · approximate
    Initial public offering on NYSE
  5. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.
  6. •
    Legal Entity Identifier issued
    LEI 549300ZQ4ZUYSAAX6P59 registered.
  7. 2021
  8. ✎
    Renamed Hims & Hers Health, Inc.
    Formerly Oaktree Acquisition Corp..
  9. 2024
  10. 💰
    Revenue passed $1 billion
    FY2024 revenue of $1.5 billion, up from $872 million in FY2023.
  11. 2025
  12. 💰
    Record revenue of $2.3 billion
    FY2025, the highest of the 7 years on record.

Events of Hims & Hers Health, Inc. from Wikidata, the company record, SEC EDGAR, the GLEIF LEI register and the company's financial years. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$1.9 B$3.8 B$5.6 B$7.5 B2023202420252026

World rank over time

▲ up 5,633 places since 2022
2022-01-07: #8481#8,48120222022-12-25: #6748#6,74820222023-07-30: #6213#6,21320232024-01-05: #5834#5,83420242026-08-01: #2986#2,98620262026-10-14: #2833#2,83320262026-10-30: #2848#2,8482026

Rank in USA: #2,389 (Jan 2022) · #1,730 (Dec 2022) · #1,683 (Jul 2023) · #1,584 (Jan 2024) · #936 (Aug 2026) · #853 (Oct 2026) · #870 (Oct 2026)

Key ratios

market cap and latest results · TTM = trailing 12 months
P/E ratio (TTM)
n/m (loss)
Price / sales (TTM)
2.4×
Price / book
12.9×
Free cash flow yield
0.8%
Net margin (TTM)
-6.7%
Operating margin
4.5%
Return on equity
-35.3%
Liabilities / assets
74.9%
Revenue growth
+59.0%
Revenue per employee
$5.9 M
Profit per employee
$323 K

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Dec 2019: revenue $83M, net income $-72M$83MFY19Fiscal year ending Dec 2020: revenue $149M, net income $-18M$149MFY20Fiscal year ending Dec 2021: revenue $272M, net income $-108M$272MFY21Fiscal year ending Dec 2022: revenue $527M, net income $-66M$527MFY22Fiscal year ending Dec 2023: revenue $872M, net income $-24M$872MFY23Fiscal year ending Dec 2024: revenue $1.5B, net income $126M$1.5BFY24Fiscal year ending Dec 2025: revenue $2.3B, net income $128M$2.3BFY25
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Dec 2025$2.3B+59.0%$106M$128M5.5%
Dec 2024$1.5B+69.3%$62M$126M8.5%
Dec 2023$872M+65.5%$-29M$-24M-2.7%
Dec 2022$527M+93.8%$-69M$-66M-12.5%
Dec 2021$272M+82.8%$-115M$-108M-39.6%
Dec 2020$149M+80.2%$-15M$-18M-12.2%
Dec 2019$83M—$-74M$-72M-87.3%

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Dec 2025$300M$243M$57M$0.51—
Dec 2024$251M$53M$198M$0.53—
Dec 2023$73M$27M$47M$-0.11—
Dec 2022$-27M$7M$-34M$-0.32—
Dec 2021$-34M——$-0.58—
Dec 2020$-2M——$-0.51—
Dec 2019$-75M——$-2.07—

Quarterly results

USD · three months to · source: SEC filings
Revenue, trailing 12 months
$2.9B
Net income, trailing 12 months
$-191M
RevenueNet income
Three months to Dec 2024 (from the annual report): revenue $481M, net income $26M$481MDec ’24Three months to Mar 2025: revenue $586M, net income $49M$586MMar ’25Three months to Jun 2025: revenue $545M, net income $43M$545MJun ’25Three months to Sep 2025: revenue $599M, net income $16M$599MSep ’25Three months to Dec 2025 (from the annual report): revenue $618M, net income $21M$618MDec ’25Three months to Mar 2026: revenue $608M, net income $-92M$608MMar ’26Three months to Jun 2026: revenue $753M, net income $-86M$753MJun ’26Three months to Sep 2026: revenue $890M, net income $-33M$890MSep ’26

Latest quarter to Sep 2026: revenue $890M (+48.6% on a year earlier), net income $-33M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Sep 2026.

Annual and quarterly reports

Premium · account

Hims & Hers Health, Inc.'s reports from the last 8 years, from the official filing system. Downloads (Excel financial statements, PDF, the report as filed, or everything as a ZIP) are for Premium subscribers — sign in.

Annual · 7

Quarterly · 22

SEC filings

Official filings of Hims & Hers Health, Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
$2.3 B
Operating income
$106 M
Net income
$128 M

For year ending December-2025 · source: SEC filing

Balance sheet

Total assets
$2.2 B
Total liabilities
$1.6 B
Total equity
$541 M

As of December-2025

Top 100 institutional investors in Hims & Hers Health, Inc.#

As of Sep 30, 2026
475 institutions held 157.1 M shares (about 67.0% of the shares outstanding) on Sep 30, 2026. The ten largest hold 39.0%. Source: SEC Form 13F filings, filed through Nov 18, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Hims & Hers Health, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1BlackRock, Inc.29,739,760+1,036,246 (+3.61%)12.69%$886 MNov 13, 2026
2Vanguard Portfolio Management LLC10,409,131-150,183 (-1.42%)4.44%$310 MNov 13, 2026
3Vanguard Capital Management LLC9,526,404-14,980 (-0.16%)4.06%$284 MNov 13, 2026
4State Street Corp8,239,957+94,258 (+1.16%)3.52%$245 MNov 12, 2026
5Divisadero Street Capital Management, LP7,344,028+1,334,523 (+22.21%)3.13%$219 MNov 16, 2026
6Morgan Stanley6,239,020-913,478 (-12.77%)2.66%$186 MNov 13, 2026
7Geode Capital Management, LLC5,630,567-51,265 (-0.90%)2.40%$168 MNov 6, 2026
8UBS Group AG4,753,288+2,092,478 (+78.64%)2.03%$142 MNov 10, 2026
9Jpmorgan Chase & Co4,752,356-14,425 (-0.30%)2.03%$142 MNov 12, 2026
10FMR LLC4,675,376+352,084 (+8.14%)1.99%$139 MNov 10, 2026
11Two Sigma Investments, LP4,369,652New1.86%$130 MNov 16, 2026
12Goldman Sachs Group Inc3,880,161-1,293,704 (-25.00%)1.66%$116 MNov 16, 2026
13Charles Schwab Investment Management Inc2,630,138+176,351 (+7.19%)1.12%$78 MNov 16, 2026
14Northern Trust Corp2,558,097-36,180 (-1.39%)1.09%$76 MNov 16, 2026
15BNP Paribas Financial Markets2,205,447+1,883,003 (+583.98%)0.94%$66 MNov 12, 2026
16Price T Rowe Associates Inc /MD/1,653,330+721,110 (+77.35%)0.71%$49 MNov 16, 2026
17Vanguard Fiduciary Trust Co1,518,964-3,285 (-0.22%)0.65%$45 MNov 13, 2026
18Bank of New York Mellon Corp1,340,979+7,833 (+0.59%)0.57%$40 MNov 5, 2026
19Bank Of America Corp /de/1,270,640-1,041,632 (-45.05%)0.54%$38 MNov 16, 2026
20Quadrature Capital Ltd1,209,178+1,121,961 (+1286.40%)0.52%$36 MNov 13, 2026
21State Of Michigan Retirement System1,207,782-1,138,500 (-48.52%)0.52%$36 MOct 27, 2026
22Corient Private Wealth LP1,188,290+1,165,563 (+5128.54%)0.51%$35 MNov 16, 2026
23Barclays PLC1,102,127+241,121 (+28.00%)0.47%$33 MNov 6, 2026
24Schroder Investment Management Group1,088,864-40,917 (-3.62%)0.46%$32 MNov 16, 2026
25Franklin Templeton Inc1,053,960+21,321 (+2.06%)0.45%$31 MNov 12, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Hims & Hers Health, Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Bienville Capital Management, LLC974,672+188,933 (+24.05%)0.42%$29 MNov 16, 2026
27Dimensional Fund Advisors LP914,688+369,045 (+67.63%)0.39%$27 MNov 4, 2026
28Foresite Capital Management V, LLC883,751+145,600 (+19.72%)0.38%$26 MNov 16, 2026
29DekaBank Deutsche Girozentrale857,000New0.37%$26 MOct 27, 2026
30Susquehanna International Group, LLP820,085+791,135 (+2732.76%)0.35%$24 MNov 16, 2026
31Walleye Capital LLC804,793+779,915 (+3134.96%)0.34%$24 MNov 13, 2026
32Casdin Capital, LLC800,000+100,000 (+14.29%)0.34%$24 MNov 16, 2026
33Baillie Gifford & Co794,827+44,336 (+5.91%)0.34%$24 MNov 9, 2026
34Citigroup Inc794,544+572,243 (+257.42%)0.34%$24 MNov 4, 2026
35Principal Financial Group Inc788,568-878,505 (-52.70%)0.34%$23 MNov 2, 2026
36Nuveen, LLC721,523-62,071 (-7.92%)0.31%$21 MNov 10, 2026
37Rhumbline Advisers631,254-2,524 (-0.40%)0.27%$19 MNov 10, 2026
38Kingdon Capital Management, L.L.C.624,278+81,778 (+15.07%)0.27%$19 MNov 16, 2026
39Capital World Investors606,726New0.26%$18 MNov 12, 2026
40Squarepoint Ops LLC565,069-52,239 (-8.46%)0.24%$17 MNov 9, 2026
41National Bank Of Canada /fi/517,246-319,709 (-38.20%)0.22%$15 MNov 16, 2026
42Jane Street Group, LLC493,244-507,240 (-50.70%)0.21%$15 MNov 12, 2026
43Citadel Advisors LLC479,984-366,952 (-43.33%)0.20%$14 MNov 16, 2026
44Marex Group Ltd466,327-507,444 (-52.11%)0.20%$14 MNov 16, 2026
45Wells Fargo & Company/mn456,430-102,959 (-18.41%)0.19%$14 MNov 16, 2026
46Wellington Management Group LLP447,512+134,049 (+42.76%)0.19%$13 MNov 16, 2026
47CI Investments Inc.439,976+161,972 (+58.26%)0.19%$13 MNov 12, 2026
48HSBC Holdings PLC435,603-196,805 (-31.12%)0.19%$13 MNov 16, 2026
49Clear Street Group Inc.430,957-558,956 (-56.47%)0.18%$13 MNov 16, 2026
50Voloridge Investment Management, LLC429,730New0.18%$13 MNov 16, 2026
51X-Square Capital, LLC427,133+1,614 (+0.38%)0.18%$13 MNov 10, 2026
52Alliancebernstein L.P.426,488-12,375 (-2.82%)0.18%$13 MNov 16, 2026
53Metavasi Capital LP422,267-124,162 (-22.72%)0.18%$13 MNov 16, 2026
54Invesco Ltd.421,406-123,078 (-22.60%)0.18%$13 MNov 12, 2026
55UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC410,950-15,027 (-3.53%)0.18%$12 MNov 16, 2026
56Swiss National Bank405,900+9,300 (+2.34%)0.17%$12 MNov 12, 2026
57Tudor Investment Corp Et Al396,003+267,207 (+207.47%)0.17%$12 MNov 16, 2026
58Greenfield Seitz Capital Management, LLC385,366+17,027 (+4.62%)0.16%$11 MOct 29, 2026
59Group One Trading LLC354,381+26,263 (+8.00%)0.15%$11 MNov 10, 2026
60NZS Capital, LLC347,780New0.15%$10 MNov 13, 2026
61Jain Global LLC344,487-231,373 (-40.18%)0.15%$10 MNov 16, 2026
62Kelly Lawrence W & Associates Inc/ca330,825-1,450 (-0.44%)0.14%$10 MNov 16, 2026
63Raymond James Financial Inc328,724-51,367 (-13.51%)0.14%$10 MNov 12, 2026
64Cantor Fitzgerald, L. P.313,806-793,570 (-71.66%)0.13%$9 MNov 16, 2026
65LMR Partners LLP286,345New0.12%$9 MNov 16, 2026
66Commonwealth Equity Services, LLC283,323-54,365 (-16.10%)0.12%$8 MNov 2, 2026
67Legal & General Group Plc268,339+6,675 (+2.55%)0.11%$8 MNov 16, 2026
68Bank Of Montreal /can/262,811-513,653 (-66.15%)0.11%$8 MNov 9, 2026
69Qube Research & Technologies Ltd256,224New0.11%$8 MNov 13, 2026
70Deutsche Bank AG\252,261-179 (-0.07%)0.11%$8 MNov 6, 2026
71Ameriprise Financial Inc249,590-14,114 (-5.35%)0.11%$7 MNov 16, 2026
72Hohimer Wealth Management, LLC249,130-120 (-0.05%)0.11%$7 MNov 4, 2026
73Wolverine Asset Management LLC241,161-10,458 (-4.16%)0.10%$7 MNov 2, 2026
74First Trust Advisors LP239,624+188,615 (+369.77%)0.10%$7 MNov 12, 2026
75Creative Planning238,305+13,099 (+5.82%)0.10%$7 MNov 2, 2026
76California State Teachers Retirement System231,754+1,005 (+0.44%)0.10%$7 MNov 13, 2026
77Nomura Asset Management International Inc.227,543-2,038 (-0.89%)0.10%$7 MNov 16, 2026
78QV Investors Inc.224,1300 (0.00%)0.10%$7 MOct 20, 2026
79California Public Employees Retirement System219,972-55,907 (-20.27%)0.09%$7 MNov 16, 2026
80MetLife Investment Management, LLC218,945-5,517 (-2.46%)0.09%$7 MNov 16, 2026
81Retirement Systems of Alabama218,089-1,102 (-0.50%)0.09%$6 MNov 4, 2026
82LPL Financial LLC216,631-42,036 (-16.25%)0.09%$6 MNov 6, 2026
83Trexquant Investment LP212,458-20,733 (-8.89%)0.09%$6 MNov 16, 2026
84VANGUARD ASSET MANAGEMENT, Ltd208,239+11,379 (+5.78%)0.09%$6 MNov 13, 2026
85Manufacturers Life Insurance Company, The205,184+10,347 (+5.31%)0.09%$6 MNov 13, 2026
86Schonfeld Strategic Advisors LLC200,579New0.09%$6 MNov 16, 2026
87AQR Capital Management LLC197,788-12,296 (-5.85%)0.08%$6 MNov 16, 2026
88Royal Bank Of Canada192,855-72,334 (-27.28%)0.08%$6 MNov 16, 2026
89Neuberger Berman Group LLC189,467+719 (+0.38%)0.08%$6 MNov 13, 2026
90FirstWave Capital Management LLC181,277-158,701 (-46.68%)0.08%$5 MNov 16, 2026
91Jump Financial, LLC179,547-59,206 (-24.80%)0.08%$5 MNov 13, 2026
92Lake Street Private Wealth, LLC179,206+1,858 (+1.05%)0.08%$5 MOct 22, 2026
93New York State Teachers Retirement System172,900-1,801 (-1.03%)0.07%$5 MOct 22, 2026
94MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.164,502+1,846 (+1.13%)0.07%$5 MNov 16, 2026
95Davidson Kempner Capital Management LP160,0120 (0.00%)0.07%$5 MNov 16, 2026
96Gilder Gagnon Howe & Co LLC150,979+17,058 (+12.74%)0.06%$4 MNov 16, 2026
97Kornitzer Capital Management Inc /KS142,740+26,885 (+23.21%)0.06%$4 MNov 3, 2026
98Verition Fund Management LLC138,792+41,429 (+42.55%)0.06%$4 MNov 13, 2026
99Connor, Clark & Lunn Investment Management Ltd.133,006New0.06%$4 MNov 10, 2026
100Millennium Management LLC132,943New0.06%$4 MNov 16, 2026

All 475 institutional investors, with who bought and sold →

Mutual funds holding Hims & Hers Health, Inc.#

247 funds in 2 countries hold shares worth $2.1 B (about 27.1% of the company). Since their previous reports 151 added shares and 84 sold, buying $146 M net. By country: USA 246 ($2.1 B), Sweden 1 ($2 M).
Mutual funds holding Hims & Hers Health, Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 iShares Core S&P Mid-Cap ETFBlackRock Fund Advisors7.25 M$251 M3.1%0.20%+5.2%Jun 30, 2026
🇺🇸 Vanguard Total Stock Market Index FundThe Vanguard Group, Inc.6.72 M$233 M2.8%0.01%+1.1%Jun 30, 2026
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors5.55 M$192 M2.3%0.23%+11%Jun 30, 2026
🇺🇸 Vanguard Small-Cap Index FundThe Vanguard Group, Inc.4.86 M$169 M2.1%0.09%+1.1%Jun 30, 2026
🇺🇸 Vanguard Small-Cap Growth Index FundThe Vanguard Group, Inc.2.80 M$97 M1.2%0.21%+4.2%Jun 30, 2026
🇺🇸 Vanguard Extended Market Index FundThe Vanguard Group, Inc.2.43 M$84 M1.0%0.09%+4.8%Jun 30, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors2.00 M$69 M0.84%0.45%+19%Jun 30, 2026
🇺🇸 JPMorgan Large Cap Growth FundJ.P. Morgan Investment Management Inc.1.98 M$69 M0.84%0.06%+0.0%Jun 30, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC2.36 M$66 M1.00%0.19%+16%Jul 31, 2026
🇺🇸 State Street SPDR S&P MidCap 400SM ETF TrustSpdr S&P Midcap 400 ETF Trust1.63 M$57 M0.69%0.20%+3.9%Jun 30, 2026
🇺🇸 iShares S&P Mid-Cap 400 Growth ETFBlackRock Fund Advisors1.27 M$44 M0.54%0.39%+0.3%Jun 30, 2026
🇺🇸 State Street SPDR Portfolio S&P 400 Mid Cap ETFSSGA Funds Management, Inc.1.07 M$37 M0.45%0.20%+5.4%Jun 30, 2026
🇺🇸 Fidelity Small Cap Growth FundFidelity Management & Research Company LLC1.23 M$34 M0.52%0.39%+186%Jul 31, 2026
🇺🇸 Principal U.S. Small-Cap ETFPrincipal Global Investors, LLC877,347$30 M0.37%1.3%+8.7%Jun 30, 2026
🇺🇸 Fidelity Extended Market Index FundFidelity Management & Research Company LLC1.07 M$28 M0.45%0.07%−1.5%May 31, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.1.05 M$28 M0.45%0.16%+3.7%May 31, 2026
🇺🇸 Schwab U.S. Small-Cap ETFCharles Schwab Investment Management, Inc.999,147$26 M0.42%0.11%−1.3%May 31, 2026
🇺🇸 Fidelity Small Cap Growth K6 FundFidelity Management & Research Company LLC642,260$18 M0.27%0.39%+194%Jul 31, 2026
🇺🇸 Fidelity Stock Selector Small Cap FundFidelity Management & Research Company LLC610,700$17 M0.26%0.23%+208%Jul 31, 2026
🇺🇸 Vanguard Health Care Index FundThe Vanguard Group, Inc.591,888$15 M0.25%0.08%+0.6%May 31, 2026
🇺🇸 U.S. Small Cap PortfolioDimensional Fund Advisors LP537,435$15 M0.23%0.08%no changeJul 31, 2026
🇺🇸 T. Rowe Price New Horizons Fund, Inc.T. Rowe Price Associates, Inc.429,667$15 M0.18%0.10%−42%Jun 30, 2026
🇺🇸 Schwab U.S. Mid-Cap ETFCharles Schwab Investment Management, Inc.563,791$15 M0.24%0.10%+0.2%May 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.525,151$15 M0.22%0.19%+17%Jul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC398,449$14 M0.17%0.23%+20%Jun 30, 2026
🇺🇸 iShares U.S. Healthcare Providers ETFBlackRock Fund Advisors373,320$13 M0.16%1.1%+53%Jun 30, 2026
🇺🇸 State Street SPDR S & P 400 Mid Cap Growth ETFSSGA Funds Management, Inc.327,704$11 M0.14%0.39%+3.3%Jun 30, 2026
🇺🇸 Fidelity Total Market Index FundFidelity Management & Research Company LLC393,783$10 M0.17%<0.01%+1.2%May 31, 2026
🇺🇸 Franklin Growth Opportunities FundFranklin Advisers, Inc.358,810$10 M0.15%0.23%newJul 31, 2026
🇺🇸 Fidelity Growth Company FundFidelity Management & Research Company LLC374,800$10 M0.16%<0.01%newMay 31, 2026
🇺🇸 BlackRock Advantage Small Cap Core FundBlackRock Advisors, LLC372,970$10 M0.16%0.19%−6.9%May 29, 2026
🇺🇸 Fidelity Series Small Cap Opportunities FundFidelity Management & Research Company LLC350,600$10 M0.15%0.21%+151%Jul 31, 2026
🇺🇸 iShares Core S&P Total U.S. Stock Market ETFBlackRock Fund Advisors275,238$10 M0.12%0.01%+2.4%Jun 30, 2026
🇺🇸 Vanguard S&P Mid-Cap 400 Index FundThe Vanguard Group, Inc.332,568$9 M0.14%0.16%+4.9%May 31, 2026
🇺🇸 Fidelity Series Total Market Index FundFidelity Management & Research Company LLC318,978$8 M0.13%<0.01%+3.5%May 31, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC234,449$8 M0.10%0.21%+9.4%Jun 30, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC281,847$8 M0.12%0.19%+17%Jul 31, 2026
🇺🇸 JNL Mid Cap Index FundJackson National Asset Management, LLC213,964$7 M0.09%0.20%+1.8%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Growth FundJ.P. Morgan Investment Management Inc.211,101$7 M0.09%0.28%−5.0%Jun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC202,515$7 M0.09%0.45%+30%Jun 30, 2026
🇺🇸 Optimum Small-Mid Cap Growth FundDelaware Management Company199,864$7 M0.08%0.73%newJun 30, 2026
🇺🇸 Emerald Growth FundRBB Fund, Inc.243,554$7 M0.10%0.46%—Jul 31, 2026
🇺🇸 iShares Core S&P U.S. Growth ETFBlackRock Fund Advisors179,124$6 M0.08%0.02%+2.1%Jun 30, 2026
🇺🇸 EQ/Mid Cap Index PortfolioEquitable Investment Management Group, LLC171,810$6 M0.07%0.20%+0.6%Jun 30, 2026
🇺🇸 Vanguard S&P Mid-Cap 400 Growth Index FundThe Vanguard Group, Inc.208,913$5 M0.09%0.30%+9.9%May 31, 2026
🇺🇸 Nuveen ESG Small-Cap ETFNuveen Fund Advisors, LLC191,493$5 M0.08%0.41%−7.5%Jul 31, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation149,500$5 M0.06%0.23%+9.4%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.192,292$5 M0.08%0.30%+2.3%May 31, 2026
🇺🇸 Vanguard Total World Stock Index FundThe Vanguard Group, Inc.175,475$5 M0.07%<0.01%+9.0%Jul 31, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC173,995$5 M0.07%0.19%+1245%Jul 31, 2026
🇺🇸 Mid Cap Index FundNorthern Trust Investments, Inc.137,755$5 M0.06%0.20%+5.1%Jun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC162,311$5 M0.07%<0.01%no changeJul 31, 2026
🇺🇸 Vanguard Explorer FundThe Vanguard Group, Inc.161,206$4 M0.07%0.02%−33%Jul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC128,070$4 M0.05%0.23%+14%Jun 30, 2026
🇺🇸 JPMorgan U.S. Small Company FundJ.P. Morgan Investment Management Inc.116,100$4 M0.05%0.36%+89%Jun 30, 2026
🇺🇸 Mid Cap Index FundThe Variable Annuity Life Insurance Company153,633$4 M0.06%0.16%−3.4%May 31, 2026
🇺🇸 Buffalo Small Cap Growth FundKornitzer Capital Management, Inc.115,855$4 M0.05%0.86%newJun 30, 2026
🇺🇸 iShares U.S. Small-Cap Equity Factor ETFBlackRock Fund Advisors142,128$4 M0.06%0.10%+2.0%Jul 31, 2026
🇺🇸 Vanguard Balanced Index FundThe Vanguard Group, Inc.113,390$4 M0.05%<0.01%−3.4%Jun 30, 2026
🇺🇸 BlackRock Advantage Small Cap Growth FundBlackRock Funds112,355$4 M0.05%0.47%+15%Jun 30, 2026
🇺🇸 Columbia Mid Cap Index FundColumbia Management Investment Advisers, LLC148,786$4 M0.06%0.15%−3.1%May 31, 2026
🇺🇸 State Street SPDR S&P Kensho New Economies Composite ETFSSGA Funds Management, Inc.111,030$4 M0.05%0.14%+215%Jun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.109,346$4 M0.05%0.23%+16%Jun 30, 2026
🇺🇸 Invesco Dorsey Wright Healthcare Momentum ETFInvesco Capital Management LLC133,217$4 M0.06%1.6%newJul 31, 2026
🇺🇸 Schwab Total Stock Market Index FundCharles Schwab Investment Management, Inc.131,448$4 M0.06%<0.01%+7.0%Jul 31, 2026
🇺🇸 Vanguard Institutional Total Stock Market Index FundThe Vanguard Group, Inc.101,478$4 M0.04%0.01%+2.1%Jun 30, 2026
🇺🇸 Index 400 Stock PortfolioMason Street Advisors, LLC98,369$3 M0.04%0.20%+1.5%Jun 30, 2026
🇺🇸 JPMorgan Small & Mid Cap Enhanced Equity ETFJ.P. Morgan Investment Management Inc.96,618$3 M0.04%0.12%+4.1%Jun 30, 2026
🇺🇸 Empower S&P Mid Cap 400 Index FundEmpower Capital Management, LLC96,557$3 M0.04%0.20%−1.9%Jun 30, 2026
🇺🇸 Invesco S&P Midcap 400 Pure Growth ETFInvesco Capital Management LLC118,879$3 M0.05%0.98%−4.8%Jul 31, 2026
🇺🇸 Amplify Online Retail ETFAmplify ETF Trust94,082$3 M0.04%3.0%+35%Jun 30, 2026
🇺🇸 Schwab U.S. Broad Market ETFCharles Schwab Investment Management, Inc.122,203$3 M0.05%<0.01%+1.6%May 31, 2026
🇺🇸 Fidelity ZERO Total Market Index FundFidelity Management & Research Company LLC115,061$3 M0.05%<0.01%+6.4%Jul 31, 2026
🇺🇸 First Trust Mid Cap Growth AlphaDEX FundFirst Trust Advisors L.P.105,897$3 M0.04%0.51%+221%Jul 31, 2026
🇺🇸 JNL/Mellon Healthcare Sector FundJackson National Asset Management, LLC83,878$3 M0.04%0.11%−4.9%Jun 30, 2026
🇺🇸 The Hartford Small Company FundHartford Funds Management Company, LLC104,355$3 M0.04%0.43%+63%Jul 31, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC103,472$3 M0.04%0.19%+16%Jul 31, 2026
🇺🇸 State Street SPDR S&P Health Care Services ETFSSGA Funds Management, Inc.81,378$3 M0.03%2.0%—Jun 30, 2026
🇺🇸 JPMorgan Active Growth ETFJ.P. Morgan Investment Management Inc.80,500$3 M0.03%0.03%+7.2%Jun 30, 2026
🇺🇸 Fidelity Growth Company K6 FundFidelity Management & Research Company LLC103,674$3 M0.04%<0.01%newMay 31, 2026
🇺🇸 EQ/AB Small Cap Growth PortfolioEquitable Investment Management Group, LLC77,570$3 M0.03%0.12%+12%Jun 30, 2026
🇺🇸 Moa Mid Cap Equity Index FundMUTUAL OF AMERICA CAPITAL MANAGEMENT LLC76,221$3 M0.03%0.20%−2.9%Jun 30, 2026
🇺🇸 LVIP Franklin Templeton Multi-Factor SMID Cap Equity FundLincoln Financial Investments Corporation75,663$3 M0.03%0.25%−0.8%Jun 30, 2026
🇺🇸 Fidelity MSCI Health Care Index ETFFidelity Management & Research Company LLC93,866$3 M0.04%0.08%+2.9%Jul 31, 2026
🇺🇸 College Retirement Equities Fund - Total Global Stock AccountTIAA-CREF Investment Management, LLC75,170$3 M0.03%<0.01%newJun 30, 2026
🇺🇸 Fidelity Series Growth Company FundFidelity Management & Research Company LLC98,200$3 M0.04%0.01%newMay 31, 2026
🇺🇸 Mid Cap Index TrustJohn Hancock Variable Trust Advisers LLC73,388$3 M0.03%0.19%−0.8%Jun 30, 2026
🇺🇸 NVIT Mid Cap Index FundNATIONWIDE FUND ADVISORS73,181$3 M0.03%0.20%+4.4%Jun 30, 2026
🇺🇸 First Trust Mid Cap Core AlphaDEX FundFirst Trust Advisors L.P.89,127$2 M0.04%0.18%newJul 31, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC71,361$2 M0.03%0.23%+10%Jun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.70,800$2 M0.03%0.08%+0.6%Jun 30, 2026
🇺🇸 JPMorgan BetaBuilders U.S. Mid Cap Equity ETFJ.P. Morgan Investment Management Inc.88,303$2 M0.04%0.12%+7.2%Jul 31, 2026
🇺🇸 MetLife Mid Cap Stock Index PortfolioBrighthouse Investment Advisers, LLC69,749$2 M0.03%0.20%−1.3%Jun 30, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC67,748$2 M0.03%0.21%+11%Jun 30, 2026
🇺🇸 JPMorgan Small Cap Blend FundJ.P. Morgan Investment Management Inc.67,099$2 M0.03%0.14%−6.5%Jun 30, 2026
🇺🇸 MidCap S&P 400 Index FundPrincipal Global Investors, LLC81,023$2 M0.03%0.16%+1.7%Jul 31, 2026
🇺🇸 Fidelity ZERO Extended Market Index FundFidelity Management & Research Company LLC78,276$2 M0.03%0.08%+6.8%Jul 31, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company81,965$2 M0.03%0.16%−1.5%May 31, 2026
🇺🇸 BNY Mellon Midcap Index Fund, Inc.BNY Mellon Investment Adviser, Inc.77,104$2 M0.03%0.16%−8.5%Jul 31, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC60,669$2 M0.03%0.23%+13%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 100 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Hims & Hers Health, Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
$1.2 M
1 purchase, 1 insider
Sold, 12 months
$19.0 M
47 sales, 8 insiders
Net, 12 months
-$17.8 M
open market only
Insiders on file
27
since
$2.0 M-$45.8 M$0Nov 2023: bought $0 (0 trades), sold $273 K (6 trades)Nov 23Dec 2023: bought $0 (0 trades), sold $1.3 M (12 trades)Jan 2024: bought $0 (0 trades), sold $1.9 M (4 trades)Feb 2024: bought $0 (0 trades), sold $15.2 M (14 trades)Mar 2024: bought $0 (0 trades), sold $8.9 M (22 trades)Apr 2024: bought $0 (0 trades), sold $5.6 M (15 trades)AprMay 2024: bought $2.0 M (1 trades), sold $16.2 M (26 trades)Jun 2024: bought $0 (0 trades), sold $25.1 M (27 trades)Jul 2024: bought $0 (0 trades), sold $8.9 M (12 trades)Aug 2024: bought $0 (0 trades), sold $6.6 M (15 trades)Sep 2024: bought $0 (0 trades), sold $7.2 M (20 trades)SepOct 2024: bought $0 (0 trades), sold $15.5 M (23 trades)Nov 2024: bought $132 K (2 trades), sold $18.1 M (28 trades)Dec 2024: bought $0 (0 trades), sold $12.8 M (24 trades)Jan 2025: bought $0 (0 trades), sold $19.5 M (30 trades)Feb 2025: bought $0 (0 trades), sold $16.3 M (25 trades)FebMar 2025: bought $0 (0 trades), sold $13.9 M (24 trades)Apr 2025: bought $0 (0 trades), sold $8.2 M (17 trades)May 2025: bought $0 (0 trades), sold $14.1 M (16 trades)Jun 2025: bought $0 (0 trades), sold $17.6 M (17 trades)Jul 2025: bought $0 (0 trades), sold $12.8 M (14 trades)JulAug 2025: bought $0 (0 trades), sold $45.8 M (13 trades)Sep 2025: bought $0 (0 trades), sold $29.4 M (21 trades)Oct 2025: bought $0 (0 trades), sold $12.7 M (15 trades)Nov 2025: bought $0 (0 trades), sold $1.1 M (3 trades)Dec 2025: bought $0 (0 trades), sold $2.4 M (6 trades)DecJan 2026: bought $0 (0 trades), sold $582 K (2 trades)Feb 2026: bought $0 (0 trades), sold $210 K (2 trades)Mar 2026: bought $0 (0 trades), sold $2.9 M (4 trades)Apr 2026: bought $0 (0 trades), sold $2.4 M (5 trades)May 2026: bought $1.2 M (1 trades), sold $188 K (1 trades)MayJun 2026: bought $0 (0 trades), sold $5.2 M (7 trades)Jul 2026: bought $0 (0 trades), sold $491 K (2 trades)Aug 2026: bought $0 (0 trades), sold $1.6 M (4 trades)Sep 2026: bought $0 (0 trades), sold $2.2 M (7 trades)Oct 2026: bought $0 (0 trades), sold $256 K (3 trades)OctNov 2026: bought $0 (0 trades), sold $571 K (3 trades)
Bought (open market)Sold (open market)Hover a month for the totals
Hims & Hers Health, Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Deborah M. AutorChief Policy Officer, DirectorSell10b5-1 plan-23,828$18.53$442 K48,961Form 4
filed Soleil BoughtonChief Legal OfficerSell10b5-1 plan-3,458$18.53$64 K311,190Form 4
filed Oluyemi OkupeChief Financial OfficerSell10b5-1 plan-3,518$18.53$65 K266,188Form 4
filed Michael ChiChief Operating OfficerOption exercise+69,769——526,429Form 4
filed Mohamed ElshenawyCTOOption exercise+188,286——373,842Form 4
filed Soleil BoughtonChief Legal OfficerOption exercise+42,262——336,148Form 4
filed Patrick Harrison CarrollChief Medical OfficerOption exercise+25,927——223,774Form 4
filed David B. WellsDirectorOption exercise+1,051——230,859Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals

Markets and events: Hims & Hers Health, Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
51.7 M
5.84 days to cover
Buybacks, Q4 2025
$80.5M
Q4 2025
Shares sold short, last 24 reportsAll stocks →
Hims & Hers Health, Inc. share buybacks by quarter
Buybacks, quarterFiscalSpent
Q4 2025Q4 2025$80.5M
Q3 2025Q3 2025$9.5M
Q2 2025Q2 2025$0M
Q1 2025Q1 2025$0M
Q4 2024Q4 2024$5M
Q3 2024Q3 2024$30M
Q2 2024Q2 2024$19.9M
Q1 2024Q1 2024$28.1M
Q4 2023Q4 2023$2M
Q3 2023Q3 2024$0M
Q2 2023Q2 2024$0M
Q1 2023Q1 2024$0M
Q4 2022Q4 2022$0M
Q3 2022Q3 2022$0M
Q2 2022Q2 2022$0M
Q1 2022Q1 2022$0M

Fails to deliver

  • : 229 shares at $29.67
  • : 46,485 shares at $27.71
  • : 19,114 shares at $28.15
  • : 23,301 shares at $28.07
  • : 462 shares at $29.38

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Hims & Hers Health, Inc. scorecard#

Passes 13 of the 23 checks that could be worked out: strongest in financial health (3 of 3), weakest in shareholder returns (0 of 3). Fiscal year 2025; market cap of Oct 30, 2026.

  • Valuation2 of 6
    • ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
    • ✗Price to book below its peers' median12.9×Price to book 12.9× against FMCG's median of 5.1×.
    • ✓Price to sales below its peers' median2.4×Price to sales 2.4× against FMCG's median of 2.5×.
    • ✗Free cash flow yield above 5%0.8%Free cash flow is 0.8% of the market value.
    • ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
    • ✓The price assumes slower growth than the last three years'25.0%The price assumes 25.0% a year for ten years; revenue grew 64.5% a year over the last three.
  • Growth5 of 6
    • ✓Revenue grew in the newest year59.0%Revenue up 59.0% in fiscal 2025.
    • ✓Revenue up more than 5% a year over three years64.5%64.5% a year over the three years to fiscal 2025.
    • ✓Faster growth over three years than its peers' median64.5%64.5% a year against FMCG's median of 0.4% (30 companies).
    • ✗Earnings per share grew in the newest year0.51 vs 0.53Diluted EPS 0.51 in fiscal 2025 against 0.53 the year before (report's currency).
    • ✓Net income higher than five years earlier$128 M$128 M in fiscal 2025 against -$18 M in 2020.
    • ✓Revenue rose in at least four of the last five years5 of 5Revenue rose in 5 of the five years to fiscal 2025.
  • Profitability3 of 5
    • ✓Profitable in the newest year$128 MNet income $128 M in fiscal 2025.
    • ✗Profitable in each of the last five years2 of 5Profitable in 2 of the five years to fiscal 2025.
    • ✗Operating margin above its peers' median4.5%4.5% against FMCG's median of 5.3% (40 companies).
    • ✓Return on equity above 15%25.2%25.2% in fiscal 2025.
    • –Return on invested capital above 10%No return on invested capital on file.
    • ✓Operating margin wider than three years earlier4.5%4.5% in fiscal 2025 against -13.0% in 2022.
  • Financial health3 of 3
    • ✓Short-term assets cover short-term liabilities1.9×Current ratio 1.90 at the end of fiscal 2025.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✓Cash from operations positive in each of the last three years3 of 3Positive in 3 of the three years to fiscal 2025.
    • ✓Altman Z-score outside the distress zone3.97Z-score 3.97 (safe zone) for fiscal 2025.
  • Shareholder returns0 of 3
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year9.1%Diluted shares up 9.1% in fiscal 2025.
    • ✗Dividends and buybacks above 3% of the market value1.3%Dividends and buybacks were 1.3% of the market value.
    • ✗Free cash flow covers dividends and buybacks$57 MFree cash flow $57 M against $90 M paid out in fiscal 2025.

Worked out from the statements as filed (sec), the medians of FMCG, the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Financial analysis, 2025#

Worked out from Hims & Hers Health, Inc.'s statements, beside the median of FMCG.

Hims & Hers Health, Inc.: main financial ratios in 2025
Ratio2025Median of peers
Operating margin4.5%5.3%
Net margin5.5%4.1%
Return on equity25.2%11.2%
Revenue growth, 3 years a year64.6%0.4%
Revenue growth59.0%1.4%
Free cash flow margin2.5%6.0%

4of 8on the Piotroski tests of financial strength

  • The share count rose 9.1% in the year.
  • Receivables grew 426% while revenue grew 59%: customers are paying later, or sales were booked ahead of cash.
  • Revenue has grown 6 years in a row.

Hims & Hers Health, Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Hims & Hers Health, Inc.: statements by fiscal year
PeriodTrendFY 2025to Dec 31, 2025FY 2024to Dec 31, 2024FY 2023to Dec 31, 2023FY 2022to Dec 31, 2022FY 2021to Dec 31, 2021FY 2020to Dec 31, 2020FY 2019to Dec 31, 2019
Income statement
Revenue2,3481,47787252727214983
Cost of revenue614303157118673938
Gross profit1,7331,17371540920410945
Selling, general and administrative————1846656
General and administrative2731681309811426r—
Operating expenses1,6281,111744477320125119
Operating income10662−29−69−115−15r−74
Interest and finance income—————3.0—
Interest expense and finance costs————00.00.4
Other non-operating income (expense)189.87.93.04.2−2.8r2.4
Income before tax12472−22−66−111−18−72
Income tax−4.4−542.0−0.0−3.10.10.1
Net income attributable to shareholders128126−24−66−108−18r−72
Earnings per share, basic0.570.58-0.11-0.32-0.58-0.51-2.07
Earnings per share, diluted0.510.53-0.11-0.32-0.58-0.51-2.07
Shares, weighted average (basic)2252162092051873535
Shares, weighted average (diluted)2582372092051873535
Balance sheet
Cash and cash equivalents22922197r477227r1.5
Short-term investments3498012413317573—
Receivables326.16.73.94.11.1—
Inventory80642222143.5—
Other current assets4.40.4r4.2r1.80.92.0r—
Current assets768396265217270113r1.7
Property, plant and equipment———3.02.21.7—
Right-of-use (leased) assets137119.64.95.10—
Goodwill2781131111111110—
Other intangible assets196431922260.1—
Long-term investments—0—————
Total assets2,155708441366421119r205
Accounts payable143914332208.1r0.0
Current liabilities40422188487915r1.0
Lease liabilities (non-current)1439.58.73.64.10—
Total liabilities1,61423197558616r8.2
Retained earnings−114−242−368−345−279−171r1.1
Shareholders' equity541477344312335−147r−140r
Total liabilities and equity2,155708441366421119r205
Cash-flow statement
Depreciation and amortization55179.57.54.11.10.3
Share-based compensation135926643675.88.0
Cash from operating activities30025173−27−34−2.5r−75
Capital expenditure−243−53−27−7.2———
Acquisitions, net of cash acquired−145−1500−4600
Cash from investing activities−1,025−19−1235−156−40r−39
Debt issued————002.1
Debt repaid———00−1.5−9.1
Shares bought back−90−83−2.000r00
Cash from financing activities730−108−11−332354895
Exchange-rate effect on cash2.5−0.3−0.0−0.1−0.1−0.0−0.0
Change in cash7.212450−25445.6−19
Report10-K10-K10-K10-K10-K10-K10-K

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

What Hims & Hers Health, Inc. sells: revenue by product line, fiscal 2025#

As the company reports it, in US dollars, with each line's share of total revenue and the change on fiscal 2024. Lines can overlap (a total and its parts), so they are not added up.

Countries and regions

  • 🇺🇸 USA$2.2 B94%
  • Rest of the World Revenue(total)$134 M5.7%

Source: SEC annual report (XBRL data) · as of Dec 31, 2025

Where Hims & Hers Health, Inc. operates: 6 countries#

Countries where the company has its headquarters, an office, subsidiaries, a branch or reported revenue. 17 subsidiaries on file.

Present, no revenue figure for the countryShare of revenue reported there:under 10%10–25%25% or moreNothing on fileDots mark countries too small to see. Hover, tap or tab to a country for its figures.
Hims & Hers Health, Inc.: countries of operation
CountryPresenceRevenue there
🇺🇸 USAHeadquarters1 office10 subsidiaries$2.2 B94%
🇩🇪 Germany3 subsidiaries—
🇬🇧 UK2 subsidiaries—
🇨🇦 Canada1 subsidiary—
🇮🇪 Ireland1 subsidiary—
🇰🇾 Cayman Islands1 office—

Source: GLEIF legal-entity register, SEC Exhibit 21 and annual reports, office addresses on file; map outlines from Natural Earth. A country without subsidiaries or offices on record is not listed even if the company sells there. How presence is decided

Executive pay at Hims & Hers Health, Inc.#

From the pay-versus-performance table of the company's proxy statement. “Actually paid” marks share awards to their current value.

CEO total pay, fiscal 2025
$23.0 M
Andrew Dudum
Other top executives, average
$17.5 M
the CEO earned 1.3× this
$100 invested is now
$210
peer group: $113
Hims & Hers Health, Inc.: executive pay by fiscal year
Fiscal yearCEO total payActually paidOther executives, average$100 invested
2025Andrew Dudum$23.0 M$159.7 M$17.5 M$210 (peers $113)
2024Andrew Dudum$24.6 M$110.3 M$7.2 M$157 (peers $98)
2023Andrew Dudum$14.4 M$21.4 M$6.5 M$58 (peers $76)
2022Andrew Dudum$10.8 M$10.7 M$5.0 M$42 (peers $47)
2021Andrew Dudum$15.2 M$26.8 M$3.3 M$42 (peers $90)

Source: SEC proxy statement (Form DEF 14A) · as of Dec 31, 2025

Events at Hims & Hers Health, Inc.#

What the company reported to the SEC within four business days (Form 8-K), newest first.

No warning signs in the last three years: no bankruptcy, delisting notice, withdrawn financial statements, auditor change, cybersecurity incident, debt called early or impairment was reported.

Directors and officers 6 · Material agreement 6 · New debt 4 · Unregistered share sale 3 · Shareholder vote 2 · Results announced 9

Hims & Hers Health, Inc.: events reported to the SEC
FiledWhat happenedFiling
Results announced8-K
Directors and officers8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Material agreementNew debt8-K
Shareholder vote8-K
Material agreementNew debt8-K
Material agreementNew debtUnregistered share sale8-K
Results announced8-K
Results announced8-K
Material agreementUnregistered share sale8-K
Results announced8-K
Directors and officers8-K
Material agreement8-K
Results announced8-K
Shareholder vote8-K
Material agreementNew debtUnregistered share sale8-K
Results announced8-K
Directors and officers8-K
Results announced8-K
Directors and officers8-K
Results announced8-K

Source: SEC EDGAR, Form 8-K item numbers · as of Nov 9, 2026

Acquisitions and funding#

5 acquisitions, $322 M paid where reported

Businesses it acquired

Acquisitions by Hims & Hers Health, Inc.
AcquiredAcquisition dateCompletionPriceStakeSource
Eucalyptus HealthDigital Health Company2025———Wikidata
Zava Global GmbH2025—$258 M—Annual report
Medici Technologies, Inc dba Livewell2025—$28 M—Annual report
Sigmund NJ, LLC, Trybe Labs2025—$5 M—Annual report
Seaview Enterprises LLC, MedisourceRx2024—$31 M—Annual report

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

Lobbying by Hims & Hers Health, Inc.#

$1.4 M spent on lobbying the US Congress and federal agencies in 2025, most often on health issues and pharmacy.

Lobbying, 2025
$1.4 M
#315 among companies on value.today
Own lobbyists
Yes
files its own reports
Firms hired
2
in 2025
2026 so far
$920 K
  • Health Issues10 reports
  • Pharmacy1 report

Lobbying firms hired in 2025

Kountoupes Denham Carr & Reid, LLC $240 K · Cassidy & Associates, Inc. $60 K

The firms' fees are part of Hims & Hers Health, Inc.'s own reported expenses, so they are not added again.

Hims & Hers Health, Inc.: lobbying spending by year
YearSpendingOwn lobbyistsReports
2026 (so far)$920 K$920 K9
2025$1.4 M$1.4 M10
2024$220 K—3
2023$20 K—1

Source: Lobbying Disclosure Act reports (Form LD-2). Filed as “Hims & Hers Health, Inc.”, “HIMS & HERS HEALTH, INC.” and “Hims & Hers Health, Inc. (formerly Hims, Inc)”. Reports round to the nearest $10,000, and one of less than $5,000 counts as zero

Discuss Hims & Hers Health, Inc.#

3 automatic updates and 0 member comments. Sign in to comment and react.

  • Results announced on 9 November 2026automatic update · Nov 9, 2026

    Hims & Hers Health, Inc. announced results on 9 November 2026 (SEC Form 8-K, item 2.02). For the quarter ended 30 September 2026: revenue of $890 million (up 49% from a year earlier) and a net loss of $33 million.

  • Insider trading in October 2026automatic update · Oct 31, 2026

    Directors and officers of Hims & Hers Health, Inc. reported open-market trades for October 2026 (SEC Forms 4 and 5): 2 insiders sold shares worth about $255,528 in 3 trades. Awards, option exercises and shares withheld for tax are not counted.

  • Mutual funds: 247 funds hold $2.1 billionautomatic update · Jul 31, 2026

    247 mutual funds in 2 countries hold shares of Hims & Hers Health, Inc. worth $2.1 billion, about 27.1% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 151 funds added shares and 84 sold; on balance they bought $146 million. Share splits are not counted as trading.

How Hims & Hers Health, Inc. compares in FMCG

  • Market cap$7.0 B · higher than 81% of 110
  • Revenue$2.3 B · higher than 69% of 104
  • Net margin-6.7% · higher than 11% of 103
  • Revenue growth59.0% · highest of 46
  • Price / sales2.4× · lower than 37% of 72
  • Price / book12.9× · lower than 11% of 71
  • FCF yield0.8% · higher than 24% of 34

Peer comparison · FMCG

CompanyMarket capP/ENet marginRev. growth
Hims & Hers Health, Inc.🇺🇸$7.0 B—-6.7%+59.0%
The Procter & Gamble Company🇺🇸$372.2 B23.2×18.2%+3.3%
L'Oréal S.A.🇫🇷$241.7 B33.3×13.9%+5.5%
Unilever PLC🇬🇧$135.7 B12.7×18.8%+0.3%
Colgate-Palmolive Company🇺🇸$74.8 B36.4×9.7%+1.4%
Hindustan Unilever Limited🇮🇳$52.2 B32.2×23.6%—
Reckitt Benckiser Group PLC🇬🇧$44.3 B10.2×22.4%+3.3%
Haleon plc🇬🇧$42.6 B19.4×15.1%+1.2%
The Estée Lauder Companies Inc.🇺🇸$39.6 B107.6×2.4%+5.0%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Oct 30, 2026
Annual results:
For year ending December-2025
Balance sheet:
As of December-2025
Employees:
As on 2021
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, Wikidata, Wikipedia, GLEIF register; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Hims & Hers Health, Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Hims & Hers Health, Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Hims & Hers Health, Inc.? Suggest a correction